TGLU Talk Series: Using Proteomic Signatures to predict IBD Risk and Early Disease by Olle Grännö from Örebro University Hospital, Sweden

Olle Grännö is a resident in clinical microbiology at Örebro University Hospital, Sweden. He defended his PhD thesis in May 2025, titled “Characterising the Phases of Inflammatory Bowel Disease: From Genetic Predisposition to Established Disease”. Olle is studying the circulating proteome and the gut microbiome in Nordic population-based cohorts, aiming to identify biomarkers capable of: (1) predict a future diagnosis of IBD and (2) forecast the early disease course in newly diagnosed patients. He is currently visiting Prof. Jack Satsangi’s research group at the Translational Gastroenterology and Liver Unit to work on the INTERCEPT project – a multicentre study aiming to explore the possibility of preventing the onset of Crohn’s disease.